Proud to see @MattRosellini taking another step in his PhD journey. Watching a young researcher grow through curiosity, commitment and scientific rigor is truly rewarding. Here with our work on chromosome 3p drivers and PI3K–AKT–mTOR alterations in #ccRCC.
@Unibo@IKCCorg
In this video @VincentWenxinXu gives an overview on the most promising biomarker to date in kidney cancer (KIM1). In the CAPLPSO clear cell trial more KIM-1 ⬇️ occurred with durva/treme vs Durva alone. Could KIM1 be better surrogate of OS than radiology. @DrChoueiri@OncoAlert
JUST IN: 2 Belzutifan (HIF2 inhibitor) phase III trials POSTIVE for Primary Endpoint in Renal Cell Carcinoma: LITEPSPAK022 (adjuvant) + LITESPARK011 (metastatic, post PD1).
BIG NEWS for GU Oncology + Kidney Cancer patients!
https://t.co/poOKpXP5nJ
https://t.co/wP9gu8ppLI
Out now our experience at @Unibo about the role of chromosome 3p mutations in mRCC patients treated with immune-based combinations or targeted therapy.
Introducing the @Fender Custom Shop Limited Edition Masterbuilt John Frusciante Stratocaster!!
For a limited run, Masterbuilder Paul Waller replicated John’s Strat with all of the dings, dents and scars that cover this infamous guitar. It features a set of three ’60s-style Strat pickups handwound by Abigail Ybarra.
Learn more: https://t.co/GND3pqmJxH